1. Home
  2. VRTS vs ARDX Comparison

VRTS vs ARDX Comparison

Compare VRTS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

N/A

Current Price

$100.77

Market Cap

790.2M

Sector

Finance

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$2.99

Market Cap

724.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTS
ARDX
Founded
1988
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.2M
724.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
VRTS
ARDX
Price
$100.77
$2.99
Analyst Decision
Sell
Strong Buy
Analyst Count
3
11
Target Price
★ $133.75
$12.50
AVG Volume (30 Days)
101.4K
★ 4.4M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
★ 9.24%
N/A
EPS Growth
★ 18.24
N/A
EPS
★ 10.96
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
N/A
$18.39
Revenue Next Year
N/A
$26.08
P/E Ratio
$9.68
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$105.53
$2.80
52 Week High
$175.66
$8.40

Technical Indicators

Market Signals
Indicator
VRTS
ARDX
Relative Strength Index (RSI) 31.03 43.02
Support Level N/A $2.88
Resistance Level $147.37 $3.38
Average True Range (ATR) 6.50 0.17
MACD -2.10 0.02
Stochastic Oscillator 2.59 30.33

Price Performance

Historical Comparison
VRTS
ARDX

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: